Published in J Rheumatol on April 01, 2010
Myositis ossificans in children: a review. Eur J Orthop Surg Traumatol (2017) 0.75
Calcinosis in rheumatic diseases. Semin Arthritis Rheum (2005) 2.67
Heterotopic ossification: a review. J Rehabil Med (2005) 2.37
Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation. Arthritis Rheum (2006) 1.23
Histologic, physical and chemical investigation of myositis ossificans traumatica. Acta Orthop Scand (1980) 0.91
Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med (2007) 3.72
DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis. J Bone Miner Res (2005) 2.46
In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions. J Biol Chem (2004) 2.25
Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain (2006) 2.22
US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum (2003) 2.21
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet (2008) 2.16
Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. J Bone Miner Res (2012) 2.05
Malignant gastrointestinal neuroectodermal tumor: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of 16 cases with a reappraisal of clear cell sarcoma-like tumors of the gastrointestinal tract. Am J Surg Pathol (2012) 2.03
Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood (2010) 1.98
Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol (2002) 1.83
COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat (2011) 1.77
Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell (2009) 1.72
Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum (2003) 1.71
Bone fragility and collagen cross-links. J Bone Miner Res (2004) 1.68
Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) (2010) 1.65
Infrared assessment of bone quality: a review. Clin Orthop Relat Res (2011) 1.63
Does sex matter in musculoskeletal health? The influence of sex and gender on musculoskeletal health. J Bone Joint Surg Am (2005) 1.61
Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns. Histopathology (2010) 1.61
Variations in nanomechanical properties and tissue composition within trabeculae from an ovine model of osteoporosis and treatment. Bone (2012) 1.60
Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture. J Bone Miner Res (2009) 1.54
Spatial variation in osteonal bone properties relative to tissue and animal age. J Bone Miner Res (2009) 1.52
Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1. Cancer Res (2005) 1.50
Identification of Differentially Expressed MicroRNAs in Osteosarcoma. Sarcoma (2011) 1.48
Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis. Arthritis Care Res (Hoboken) (2010) 1.48
Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone (2009) 1.47
Effects of surface roughness and maximum load on the mechanical properties of cancellous bone measured by nanoindentation. J Biomed Mater Res A (2006) 1.46
Effects of tissue age on bone tissue material composition and nanomechanical properties in the rat cortex. J Biomed Mater Res A (2010) 1.45
Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis. Arch Dermatol (2011) 1.41
Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. Arthritis Rheum (2008) 1.36
Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy. Arthritis Rheum (2009) 1.36
Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference. Arthritis Care Res (Hoboken) (2010) 1.32
Dilatational band formation in bone. Proc Natl Acad Sci U S A (2012) 1.32
Infrared spectroscopic characterization of mineralized tissues. Vib Spectrosc (2005) 1.31
Mineral changes in osteoporosis: a review. Clin Orthop Relat Res (2006) 1.31
Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthritis Rheum (2009) 1.30
Contribution of mineral to bone structural behavior and tissue mechanical properties. Calcif Tissue Int (2010) 1.30
Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway. J Biol Chem (2005) 1.27
A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells. J Biol Chem (2007) 1.25
Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation. Arthritis Rheum (2006) 1.23
Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. J Rheumatol (2004) 1.21
Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis. Am J Pathol (2013) 1.20
DSPP effects on in vivo bone mineralization. Bone (2008) 1.19
Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene (2003) 1.19
In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res (2002) 1.17
Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Int J Biochem Cell Biol (2010) 1.17
Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Bone (2005) 1.13
Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum (2013) 1.12
Spindle cell rhabdomyosarcoma of the tongue in an infant: a case report with emphasis on differential diagnosis of childhood spindle cell lesions. Pathol Res Pract (2004) 1.11
Bone quality: from bench to bedside: opening editorial comment. Clin Orthop Relat Res (2011) 1.09
Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2. J Biol Chem (2003) 1.08
Fourier transform infrared imaging microspectroscopy and tissue-level mechanical testing reveal intraspecies variation in mouse bone mineral and matrix composition. Calcif Tissue Int (2008) 1.08
MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement. Clin Immunol (2006) 1.08
Fourier transform-infrared microspectroscopy and microscopic imaging. Methods Mol Biol (2008) 1.06
Familial aggregation of autoimmune disease in juvenile dermatomyositis. Pediatrics (2011) 1.06
Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis. Arthritis Rheum (2008) 1.05
The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis. Arthritis Care Res (Hoboken) (2010) 1.05
Increased plasma thrombospondin-1 (TSP-1) levels are associated with the TNF alpha-308A allele in children with juvenile dermatomyositis. Clin Immunol (2002) 1.04
Microstructure and nanomechanical properties in osteons relate to tissue and animal age. J Biomech (2010) 1.03
Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model. Pediatr Res (2002) 1.03
Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development. J Biol Chem (2011) 1.02
Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J Bone Miner Res (2003) 1.02
Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis. BMC Immunol (2008) 1.01
Gene-gene-sex interaction in cytokine gene polymorphisms revealed by serum interferon alpha phenotype in juvenile dermatomyositis. J Pediatr (2010) 1.00
Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells. Arthritis Rheum (2010) 1.00
Spectroscopically determined collagen Pyr/deH-DHLNL cross-link ratio and crystallinity indices differ markedly in recombinant congenic mice with divergent calculated bone tissue strength. Connect Tissue Res (2003) 1.00
Fourier transform infrared imaging of femoral neck bone: reduced heterogeneity of mineral-to-matrix and carbonate-to-phosphate and more variable crystallinity in treatment-naive fracture cases compared with fracture-free controls. J Bone Miner Res (2013) 0.99
Decorin modulates collagen matrix assembly and mineralization. Matrix Biol (2008) 0.98
Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1-34) for 18 months. J Bone Miner Res (2003) 0.97
High WT1 gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event-free survival. Br J Haematol (2009) 0.96
Senescence-initiated reversal of drug resistance: specific role of cathepsin L. Cancer Res (2004) 0.95
Bone tissue composition varies across anatomic sites in the proximal femur and the iliac crest. J Orthop Res (2011) 0.95
Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism. Am J Physiol Cell Physiol (2008) 0.94
Atypical subtrochanteric femoral shaft fractures: role for mechanics and bone quality. Arthritis Res Ther (2012) 0.94
Clarifying the boundaries between the inflammatory and dystrophic myopathies: insights from molecular diagnostics and microarrays. Rheum Dis Clin North Am (2002) 0.94
Milk fat globule-EGF factor 8 is a critical protein for healing of dextran sodium sulfate-induced acute colitis in mice. Mol Med (2011) 0.93
Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis. Arthritis Rheum (2002) 0.93
Autoantibody to signal recognition particle in African American girls with juvenile polymyositis. J Rheumatol (2008) 0.93
The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis. Arthritis Rheum (2008) 0.92
Juvenile dermatomyositis calcifications selectively displayed markers of bone formation. Arthritis Rheum (2009) 0.92
Serum neopterin levels as a diagnostic marker of hemophagocytic lymphohistiocytosis syndrome. Clin Vaccine Immunol (2011) 0.91
Regulating in vivo calcification of alginate microbeads. Biomaterials (2010) 0.90
RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis. Arthritis Rheum (2007) 0.90
Non-enzymatic glycation of chondrocyte-seeded collagen gels for cartilage tissue engineering. J Orthop Res (2008) 0.90
Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases. Hum Pathol (2007) 0.90
A new complication of stem cell transplantation: measles inclusion body encephalitis. Pediatrics (2004) 0.88
Expression of glypican 3 in ovarian and extragonadal germ cell tumors. Am J Clin Pathol (2008) 0.87
Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis. J Pediatr (2011) 0.87
Characterization of dystrophic calcification induced in mice by cardiotoxin. Calcif Tissue Int (2009) 0.86
Chondrocyte apoptosis is not essential for cartilage calcification: evidence from an in vitro avian model. J Cell Biochem (2007) 0.86
Interferon-α induction and detection of anti-ro, anti-la, anti-sm, and anti-rnp autoantibodies by autoantigen microarray analysis in juvenile dermatomyositis. Arthritis Rheum (2013) 0.86
Expression of phosphophoryn is sufficient for the induction of matrix mineralization by mammalian cells. J Biol Chem (2011) 0.86
Ovarian teratoma mimicking features of juvenile dermatomyositis in a child. Pediatrics (2011) 0.86
Primary cutaneous alveolar rhabdomyosarcoma of the perineum. Arch Pathol Lab Med (2002) 0.85
Release of gentamicin from a tricalcium phosphate bone implant. J Orthop Res (2007) 0.85
Genetic variation in mouse femoral tissue-level mineral content underlies differences in whole bone mechanical properties. Cells Tissues Organs (2008) 0.84
Heat and radiofrequency plasma glow discharge pretreatment of a titanium alloy: evidence [corrected] for enhanced osteoinductive properties. J Cell Biochem (2013) 0.84
Inflammatory myofibroblastic tumor (inflammatory pseudotumor) of the neck infiltrating the trachea. J Pediatr Surg (2004) 0.84